179 related articles for article (PubMed ID: 23939917)
21. Second primary malignancy risk among patients with gastric cancer: a nationwide population-based study in Taiwan.
Chen SC; Liu CJ; Hu YW; Yeh CM; Hu LY; Wang YP; Hung YP; Tzeng CH; Chiou TJ; Chen TJ; Teng CJ
Gastric Cancer; 2016 Apr; 19(2):490-497. PubMed ID: 25772342
[TBL] [Abstract][Full Text] [Related]
22. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
Spanogle JP; Clarke CA; Aroner S; Swetter SM
J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
[TBL] [Abstract][Full Text] [Related]
23. Increased risk of certain second primary malignancies in patients treated for well-differentiated thyroid cancer.
Hakala TT; Sand JA; Jukkola A; Huhtala HS; Metso S; Kellokumpu-Lehtinen PL
Int J Clin Oncol; 2016 Apr; 21(2):231-239. PubMed ID: 26410770
[TBL] [Abstract][Full Text] [Related]
24. The relative risk of second primary cancers in Austria's western states: a retrospective cohort study.
Preyer O; Concin N; Obermair A; Concin H; Ulmer H; Oberaigner W
BMC Cancer; 2017 Oct; 17(1):699. PubMed ID: 29065867
[TBL] [Abstract][Full Text] [Related]
25. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
Marti JL; Jain KS; Morris LG
Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829
[TBL] [Abstract][Full Text] [Related]
26. Co-occurrence of second primary malignancy in patients with thyroid cancer.
Hsu CH; Huang CL; Hsu YH; Iqbal U; Nguyen PA; Jian WS
QJM; 2014 Aug; 107(8):643-8. PubMed ID: 24623860
[TBL] [Abstract][Full Text] [Related]
27. Elevated risks of subsequent primary malignancies in patients with thyroid cancer: a nationwide, population-based study in Korea.
Cho YY; Lim J; Oh CM; Ryu J; Jung KW; Chung JH; Won YJ; Kim SW
Cancer; 2015 Jan; 121(2):259-68. PubMed ID: 25223713
[TBL] [Abstract][Full Text] [Related]
28. Second primary malignancies after ovarian cancer: A SEER-based analysis (1975-2016).
Yang Z; Liu X; Yang X; Liao QP
Taiwan J Obstet Gynecol; 2022 Jan; 61(1):80-85. PubMed ID: 35181052
[TBL] [Abstract][Full Text] [Related]
29. Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012.
Crocetti E; Mattioli V; Buzzoni C; Franceschi S; Serraino D; Vaccarella S; Ferretti S; Busco S; Fedeli U; Varvarà M; Falcini F; Zorzi M; Carrozzi G; Mazzucco W; Gasparotti C; Iacovacci S; Toffolutti F; Cavallo R; Stracci F; Russo AG; Caldarella A; Rosso S; Musolino A; Mangone L; Casella C; Fusco M; Tagliabue G; Piras D; Tumino R; Guarda L; Dinaro YM; Piffer S; Pinna P; Mazzoleni G; Fanetti AC; Dal Maso L;
Cancer Med; 2021 Oct; 10(19):6855-6867. PubMed ID: 34533289
[TBL] [Abstract][Full Text] [Related]
30. Thyroid malignancies in survivors of Hodgkin lymphoma.
Michaelson EM; Chen YH; Silver B; Tishler RB; Marcus KJ; Stevenson MA; Ng AK
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):636-41. PubMed ID: 24521679
[TBL] [Abstract][Full Text] [Related]
31. Risk of second malignancies among survivors of pediatric thyroid cancer.
Adly MH; Sobhy M; Rezk MA; Ishak M; Afifi MA; Shafie AE; Ali MA; Zekri W; Alfaar AS; Rashed WM
Int J Clin Oncol; 2018 Aug; 23(4):625-633. PubMed ID: 29492793
[TBL] [Abstract][Full Text] [Related]
32. Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice.
Cheng Y; Huang Z; Liao Q; Yu X; Jiang H; He Y; Yao S; Nie S; Liu L
PLoS One; 2020; 15(6):e0232800. PubMed ID: 32497148
[TBL] [Abstract][Full Text] [Related]
33. The Risk of Second Primary Malignancies in Patients With Lung Neuroendocrine Tumors: A Population-Based Study on SEER Database.
Bu X; Wang X; Wei L; Liu J; Chen M
Curr Probl Cancer; 2020 Dec; 44(6):100613. PubMed ID: 32563531
[TBL] [Abstract][Full Text] [Related]
34. Filling the gaps in the research about second primary malignancies after bladder cancer: Focus on race and histology.
Othmane B; Yi Z; Zhang C; Chen J; Zu X; Fan B
Front Public Health; 2022; 10():1036722. PubMed ID: 36466542
[TBL] [Abstract][Full Text] [Related]
35. Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study.
Teng CJ; Huon LK; Hu YW; Yeh CM; Chao Y; Yang MH; Chen TJ; Hung YP; Liu CJ
Medicine (Baltimore); 2015 Oct; 94(43):e1803. PubMed ID: 26512575
[TBL] [Abstract][Full Text] [Related]
36. Elevated risk of human papillomavirus-related second cancers in survivors of anal canal cancer.
Nelson RA; Lai LL
Cancer; 2017 Oct; 123(20):4013-4021. PubMed ID: 28608917
[TBL] [Abstract][Full Text] [Related]
37. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study.
Maule M; Scélo G; Pastore G; Brennan P; Hemminki K; Tracey E; Sankila R; Weiderpass E; Olsen JH; McBride ML; Brewster DH; Pompe-Kirn V; Kliewer EV; Chia KS; Tonita JM; Martos C; Jonasson JG; Merletti F; Boffetta P
J Natl Cancer Inst; 2007 May; 99(10):790-800. PubMed ID: 17505074
[TBL] [Abstract][Full Text] [Related]
38. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
[TBL] [Abstract][Full Text] [Related]
39. The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979-2003).
Chen MC; Feng IJ; Lu CH; Chen CC; Lin JT; Huang SH; Lee KD
Ann Oncol; 2008 Jun; 19(6):1180-6. PubMed ID: 18238781
[TBL] [Abstract][Full Text] [Related]
40. Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.
Kumar V; Ailawadhi S; Bojanini L; Mehta A; Biswas S; Sher T; Roy V; Vishnu P; Marin-Acevedo J; Alegria VR; Paulus A; Aulakh S; Iqbal M; Manochakian R; Tan W; Chanan-Khan A; Ailawadhi M
Blood Cancer J; 2019 Sep; 9(10):75. PubMed ID: 31570695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
